JP2023547728A5 - - Google Patents
Info
- Publication number
- JP2023547728A5 JP2023547728A5 JP2023527970A JP2023527970A JP2023547728A5 JP 2023547728 A5 JP2023547728 A5 JP 2023547728A5 JP 2023527970 A JP2023527970 A JP 2023527970A JP 2023527970 A JP2023527970 A JP 2023527970A JP 2023547728 A5 JP2023547728 A5 JP 2023547728A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- administered
- viral infection
- aat
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20206287.3 | 2020-11-06 | ||
| EP20206287.3A EP3995130A1 (en) | 2020-11-06 | 2020-11-06 | A composition comprising extra-cellular vesicles from mesenchymal stem cells and alpha-1 antitrypsin for the treatment of viral infections |
| EP21159620 | 2021-02-26 | ||
| EP21159620.0 | 2021-02-26 | ||
| PCT/EP2021/080936 WO2022096708A1 (en) | 2020-11-06 | 2021-11-08 | A composition comprising extra-cellular vesicles from mesenchymal stem cells and alpha-1 antitrypsin for the treatment of viral infections |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023547728A JP2023547728A (ja) | 2023-11-13 |
| JP2023547728A5 true JP2023547728A5 (https=) | 2024-11-12 |
Family
ID=78806458
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023527970A Pending JP2023547728A (ja) | 2020-11-06 | 2021-11-08 | 間葉系幹細胞由来の細胞外小胞およびアルファ－１アンチトリプシンを含むウイルス感染症治療用組成物 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20230414730A1 (https=) |
| EP (1) | EP4240323A1 (https=) |
| JP (1) | JP2023547728A (https=) |
| AU (1) | AU2021375735A1 (https=) |
| CA (1) | CA3200691A1 (https=) |
| IL (1) | IL302649A (https=) |
| WO (1) | WO2022096708A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3801028A4 (en) | 2018-05-30 | 2022-04-13 | Direct Biologics LLC | A growth factor and extracellular vesicle frozen or powdered additive comprising a mesenchymal stem cell (msc) preparation and methods of use |
| US12569517B2 (en) | 2019-02-07 | 2026-03-10 | Direct Biologics, Llc | Method for treating osteoarthritis with mesenchymal stem cell exosomes |
| US12213995B2 (en) | 2019-07-18 | 2025-02-04 | Direct Biologics, Llc | Preparations comprising mesenchymal stem cells and cannabinoids and methods of their use |
| KR20230004709A (ko) | 2020-04-22 | 2023-01-06 | 다이렉트 바이오로직스 엘엘씨 | 감염성 질환과 연관된 염증성 병태를 치료하기 위한 방법 및 조성물 |
| CN115381857B (zh) * | 2022-10-28 | 2023-02-03 | 上海市东方医院（同济大学附属东方医院） | 间充质干细胞在制备治疗hpv持续感染的药物中的应用 |
| EP4680254A1 (en) * | 2023-03-17 | 2026-01-21 | MAM Holdings of West Florida, L.L.C. | Mesenchymal stem cell-derived exosome drug delivery for cancer and other disorders |
| US12502407B2 (en) | 2024-04-25 | 2025-12-23 | Direct Biologics, Llc | Treatment of fistula with bone marrow mesenchymal stem cell derived extracellular vesicles |
| WO2025227013A1 (en) * | 2024-04-26 | 2025-10-30 | Musc Foundation For Research Development | Extracellular vesicles from alpha-1 antitrypsin overexpressing cells |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5376633A (en) * | 1992-09-30 | 1994-12-27 | Lezdey; John | Method for deactivating viruses in blood component containers |
| EP1366175B1 (en) * | 2000-12-18 | 2008-01-23 | Arriva Pharmaceuticals, Inc. | Multifunctional protease inhibitors and their use in treatment of disease |
| EP2148693A4 (en) * | 2007-04-20 | 2010-06-02 | Univ Colorado | ALPHA-I-ANTITRYPINE WITHOUT SIGNIFICANT SERINE PROTEASE INHIBITOR ACTIVITY |
| RU2539099C2 (ru) | 2009-04-13 | 2015-01-10 | Апцет Гмбх Унд Ко.Кг | Сконструированные мезенхимальные стволовые клетки и способ их применения для лечения опухолей |
| US9901600B2 (en) * | 2011-03-11 | 2018-02-27 | Children's Medical Center Corporation | Methods and compositions relating to mesenchymal stem cell exosomes |
| PL3242933T3 (pl) * | 2015-01-08 | 2019-08-30 | Apceth Gmbh & Co. Kg | Zmodyfikowane genetycznie mezenchymalne komórki macierzyste wykazujące ekspresję alfa-1 antytrypsyny (aat) |
| WO2016146819A1 (en) * | 2015-03-18 | 2016-09-22 | Apceth Gmbh & Co. Kg | Hypoxia-induced expression of therapeutic proteins in mesenchymal stem cells |
| CA3117961A1 (en) * | 2018-10-29 | 2020-05-07 | Spin Therapeutics, Llc | Compositions and methods for alpha-1-antitrypsin disorders |
-
2021
- 2021-11-08 AU AU2021375735A patent/AU2021375735A1/en not_active Abandoned
- 2021-11-08 EP EP21815373.2A patent/EP4240323A1/en active Pending
- 2021-11-08 CA CA3200691A patent/CA3200691A1/en active Pending
- 2021-11-08 WO PCT/EP2021/080936 patent/WO2022096708A1/en not_active Ceased
- 2021-11-08 US US18/035,707 patent/US20230414730A1/en active Pending
- 2021-11-08 IL IL302649A patent/IL302649A/en unknown
- 2021-11-08 JP JP2023527970A patent/JP2023547728A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023547728A5 (https=) | ||
| US8387895B2 (en) | Inhalation nebulizer | |
| US8336545B2 (en) | Methods and systems for operating an aerosol generator | |
| Wildhaber et al. | Aerosol delivery to wheezy infants: a comparison between a nebulizer and two small volume spacers | |
| US20120080030A1 (en) | Mouthpiece and Flow Rate Controller for Intrapulmonary Delivery Devices | |
| JP2008536546A5 (https=) | ||
| Lødrup Carlsen et al. | How much nebulised budesonide reaches infants and toddlers? | |
| CA2425489A1 (en) | Therapeutic use of aerosolized s-nitrosoglutathione in cystic fibrosis | |
| AU2021261049A1 (en) | Products of manufacture and methods for treating, ameliorating or preventing microbial infections | |
| US20210353650A1 (en) | Pharmaceutical formulation containing remdesivir and its active metabolites for dry powder inhalation | |
| IT202000005026A1 (it) | Lattoferrina per uso inalatorio ad azione antivirale | |
| JP2023544685A (ja) | 吸入ルートを介するソフトミスト吸入器又は振動型メッシュ式噴霧器を用いた新型コロナウイルス感染症を含むウイルス性肺疾患の治療における抗ウイルス性、抗マラリア性及び／又は粘液溶解性を備える活性物質の使用 | |
| Dolovich | Aerosol delivery to children: what to use, how to choose | |
| WO2022034557A1 (en) | Intravenous and oral inhalation anti-viral compositions and methods | |
| JP2019504040A (ja) | 中等度〜重度のインフルエンザの処置 | |
| CA2701388C (en) | Calcium glycerophosphate for treating and preventing respiratory diseases or conditions | |
| JP2010189301A (ja) | 新型インフルエンザ感染症に対する医薬組成物およびその利用 | |
| JP2024546179A5 (https=) | ||
| O′ Callaghan | Targeting drug delivery to the lungs by inhalation | |
| WO2022063320A1 (zh) | 一种抑制呼吸道病毒的组合物及呼吸道病毒防治方法 | |
| CN116033903A (zh) | 奎宁及其产生先天免疫应答的用途 | |
| JP2002030000A (ja) | 風邪根本治療法 | |
| EP3906934B1 (en) | Application of dalargin for the prevention of viral respiratory infections and prevention of the development of complications during viral respiratory infections | |
| EP4005565A1 (en) | Novel uses of adamantane derivatives | |
| Businco et al. | Efficacy of Mucoregulatory Therapies Administered by Micronized Vaporization Compared to Nasal Spray in the Treatment of Upper Airway Respiratory Inflammation |